Diagnostic capsule as well as preparation method and application thereof

By adjusting the material proportion and structural design in the Pathfin capsule and controlling its disintegration time, the problem of risk of Pathfin capsule retention is solved, and safety and reliability in the judgment of intestinal conditions is achieved, ensuring the capsule endoscopy examination Validity.

CN119055221APending Publication Date: 2024-12-03CHONGQING JINSHAN SCI & TECH GRP
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411276864.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-11
Publication Date
2024-12-03

AI Technical Summary

Technical Problem

The existing trail capsules are at a high risk of retention in the human body, especially in the case of special anatomical position of the small intestine, which is difficult to remove and may lead to serious consequences.

Method used

A pathfinding capsule consisting of the first disintegration, the second disintegration and the capsule coating was designed, and by adjusting the ratio of anhydrous lactose, starch, talc, tartaric acid, sodium bicarbonate and crosslinked polyvinylpyrrolidone, combined with The width and length of the isolation belt control the disintegration time of the capsule to ensure that it is discharged from the body within a specific time and avoid retention.

Benefits of technology

It effectively reduces the risk of retention of the pathfinder capsule, ensures safety and reliability when judging intestinal conditions, avoids unnecessary examinations or surgeries, and improves the feasibility of capsule endoscopy.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure FT_1
    Figure FT_1
  • Figure SMS_1
    Figure SMS_1
  • Figure SMS_2
    Figure SMS_2
Patent Text Reader

Abstract

The invention provides a pathfinding capsule. The pathfinding capsule is composed of a first disintegrating body, a second disintegrating body and a capsule coating, the first disintegrating bodies are of semi-capsule-shaped solid structures and are arranged at the two ends of the pathfinding capsule; the second disintegration body is of a cylindrical solid structure, the diameter of the second disintegration body is the same as that of the first disintegration body, and the second disintegration body and the first disintegration body form a capsule shape; the part, which is not provided with the capsule coating, of the surface of the second disintegrating body is an isolation belt; the first disintegrating body is prepared from the following raw materials: anhydrous lactose, starch, talcum powder, tartaric acid, sodium bicarbonate and a contrast agent; the second disintegrating body is prepared from the following raw materials: anhydrous lactose, starch, talcum powder and cross-linked polyvinylpyrrolidone; according to the path-finding capsule provided by the invention, the path-finding capsule can be discharged out of the body within a specific time without being retained in the body by limiting the raw materials and proportions in the first disintegration body and the second disintegration body as well as the length of the isolation belt and the second disintegration body.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of capsule endoscope and medical equipment, and in particular to a pathfinder capsule, a preparation method thereof and application thereof. Background Art

[0002] In the process of medical diagnosis, capsule endoscopy has been widely used and recognized by medical staff and patients due to its advantages of being painless, easy to tolerate, easy to operate, and non-invasive. In clinical examinations of capsule endoscopy, doctors found that some patients may have the risk of capsule retention in the body due to intestinal stenosis caused by tumors or various diseases. Because normal capsule endoscopes are non-degradable, if the capsule is retained in the body, it must be removed, otherwise it will lead to serious consequences; and unlike the stomach and colon, the small intestine has a special anatomical position, and it is difficult to remove the capsule after it is retained, and sometimes even requires laparotomy, which brings great pain to patients and even causes medical disputes. Therefore, a method is needed to accurately judge whether the intestinal conditions are suitable for capsule endoscopy; this method is not only non-invasive, safe, but also reliable, and neither allows patients to undergo unnecessary examinations or operations, nor does it allow patients to lose the opportunity to use capsule endoscopy to examine diseases. In view of this, through continuous exploration, researchers have gradually developed biodegradable pathfinder capsules in the body. The pathfinder capsules can make advance judgments on patients undergoing gastrointestinal endoscopy to understand whether the patients have the above-mentioned intestinal stenosis and other problems, and then determine whether the patients can undergo gastrointestinal capsule endoscopy.

[0003] The pathfinder capsule in the prior art consists of two parts: a capsule body and a radio detector. The capsule body is exactly the same in shape and size as a gastrointestinal capsule endoscope, and is mainly made of degradable lactose material. It contains barium and wireless radio frequency sensors that can be developed under X-rays, but does not contain the same lenses and electronic components as the gastrointestinal capsule endoscope. This pathfinder capsule has time indicators at both ends. When it encounters a narrow part in the body and is trapped, the time indicator of the capsule body can be dissolved by the digestive fluid, thereby degrading the entire capsule body. However, the above-mentioned pathfinder capsule contains wireless radio frequency sensors and barium developers. Wireless radio frequency sensors are mostly non-degradable electronic devices, and there is still a certain risk of being trapped after entering the human body. Summary of the invention

[0004] The technical problem solved by the present invention is to provide a pathfinder capsule. The pathfinder capsule provided in the present application can accurately judge the intestinal conditions and can effectively reduce the risk of the pathfinder capsule being retained in the body.

[0005] In view of this, the present application provides a pathfinder capsule, which is composed of a first disintegrating body, a second disintegrating body and a capsule coating;

[0006] The first disintegrating body is a semi-capsule-shaped solid structure, which is arranged at both ends of the pathfinder capsule; the second disintegrating body is a cylindrical solid structure, whose diameter is the same as that of the first disintegrating body, and forms a capsule shape with the first disintegrating body; the capsule coating is arranged on the surface of the first disintegrating body and the surfaces at both ends of the second disintegrating body, and the portion of the surface of the second disintegrating body that is not provided with the capsule coating is an isolation zone;

[0007] The raw materials for preparing the first disintegrating body include: 50-60wt% anhydrous lactose, 5-10wt% starch, 2-5wt% talc, 10-15wt% tartaric acid, 10-15wt% sodium bicarbonate, and 10-15wt% contrast agent;

[0008] The raw materials for preparing the second disintegrating body include: 50% to 60% anhydrous lactose, 20% to 30% starch, 2% to 10% talc, and 5% to 15% cross-linked polyvinyl pyrrolidone;

[0009] The width of the isolation zone is 1-10 mm; the length of the second disintegrated body is 7-20 mm.

[0010] Preferably, the compression density of the second disintegrated body is 1-1.5 g / cm 3 The compression density of the first disintegrated body is 1.4-1.8 g / cm 3 .

[0011] Preferably, the raw materials for preparing the capsule coating include one or more of parylene, ethyl cellulose and zein, and the thickness of the capsule coating is 10-100 μm.

[0012] Preferably, the raw materials for preparing the first disintegrating body include: 52-58wt% anhydrous lactose, 6-8wt% starch, 3-4wt% talc, 12-14wt% tartaric acid, 12-14wt% sodium bicarbonate, and 11-14wt% contrast agent;

[0013] The raw materials for preparing the second disintegrating body include: 52% to 58% anhydrous lactose, 22% to 27% starch, 3% to 8% talc, and 6% to 14% cross-linked polyvinyl pyrrolidone.

[0014] Preferably, the width of the isolation zone is 3-6 mm; and the length of the second disintegrating body is 10-15 mm.

[0015] The present application also provides a method for preparing the pathfinder capsule, comprising the following steps:

[0016] S1) mixing anhydrous lactose, starch, talcum powder, tartaric acid, sodium bicarbonate and a contrast agent according to a proportion to obtain a first mixture, placing the first mixture in a hemispherical and cylindrical semi-capsule-shaped mold for compression to obtain a first disintegrating body;

[0017] Mixing anhydrous lactose, starch, talc and cross-linked polyvinyl pyrrolidone in a certain proportion to obtain a second mixture, and placing the second mixture in a cylindrical mold for compression to obtain a second disintegrating body;

[0018] S2) connecting the first disintegrating body and the second disintegrating body to obtain an initial pathfinder capsule;

[0019] S3) preparing a capsule coating at a position of the initial pathfinder capsule except the isolation zone to obtain a pathfinder capsule.

[0020] Preferably, in step S1), in the step of obtaining the first disintegrated body, the pressing pressure is 1-5T and the time is 1-5min; in the step of obtaining the second disintegrated body, the pressing pressure is 1-5T and the time is 1-5min.

[0021] Preferably, step S3) is specifically:

[0022] The isolation belt of the initial pathfinder capsule is covered, and then the coating liquid is sprayed on the surface of the initial capsule by using a spray gun; the coating liquid includes one of parylene, ethyl cellulose or corn protein, and the pressure of the spray gun is 1-10 kg / cm 2 .

[0023] The present application also provides the use of a pathfinder capsule in determining intestinal obstruction conditions, wherein the pathfinder capsule is the pathfinder capsule described above or the pathfinder capsule prepared by the preparation method described above.

[0024] Preferably, the application is specifically:

[0025] Administer the pathfinder capsule and observe whether the pathfinder capsule is completely discharged within 30 hours;

[0026] If so, capsule endoscopy is appropriate;

[0027] If not, capsule endoscopy is not appropriate.

[0028] The present application provides a pathfinder capsule, which is composed of a first disintegrating body, a second disintegrating body and a capsule coating, wherein the raw materials for preparing the first disintegrating body include anhydrous lactose, starch, talcum powder, tartaric acid, sodium bicarbonate and contrast agent; the raw materials for preparing the second disintegrating body include anhydrous lactose, starch, talcum powder and cross-linked polyvinyl pyrrolidone; and the width of the isolation zone ranges from 1 to 10 mm; the length of the second disintegrating body ranges from 7 to 20 mm. The pathfinder capsule provided by the present application is limited by the raw materials and proportions in the first disintegrating body and the second disintegrating body, and the length of the isolation zone and the second disintegrating body, so that the pathfinder capsule can be discharged from the body at a specific time and will not be retained in the body; at the same time, the contact surface between the pathfinder capsule and the digestive fluid is 360°, which can effectively prevent blockage when the pathfinder capsule disintegrates, and avoid the problem of being unable to disintegrate and being retained in the body. BRIEF DESCRIPTION OF THE DRAWINGS

[0029] Figure 1 This is a schematic diagram of the structure of the pathfinder capsule of the present invention. DETAILED DESCRIPTION

[0030] In order to further understand the present invention, preferred embodiments of the present invention are described below in conjunction with examples. However, it should be understood that these descriptions are only for further illustrating the features and advantages of the present invention, rather than limiting the claims of the present invention.

[0031] In view of the risk of pathfinder capsules being retained in the human body in the prior art, the present application provides a pathfinder capsule, which limits the selection of raw materials and the ratio of raw materials in the first disintegrating body and the second disintegrating body in the pathfinder capsule, and limits the length of the isolation zone and the second disintegrating body, so that when the pathfinder capsule is applied in the human body, the time for the pathfinder capsule to be discharged from the body can be flexibly adjusted as needed, effectively avoiding the retention of the pathfinder capsule in the human body. Specifically, an embodiment of the present invention discloses a pathfinder capsule, which is composed of a first disintegrating body, a second disintegrating body and a capsule coating;

[0032] The first disintegrating body is a solid structure in the shape of a semi-capsule and is arranged at both ends of the pathfinder capsule; the diameter of the second disintegrating body is the same as that of the first disintegrating body, and the second disintegrating body forms a capsule shape with the first disintegrating body, and the second disintegrating body is a solid structure; the capsule coating is arranged on the surfaces of both ends of the first disintegrating body and the second disintegrating body, and the portion of the surface of the second disintegrating body where the capsule coating is not arranged is an isolation zone;

[0033] The raw materials for preparing the first disintegrating body include: 50-60wt% anhydrous lactose, 5-10wt% starch, 2-5wt% talc, 10-15wt% tartaric acid, 10-15wt% sodium bicarbonate, and 10-15wt% contrast agent;

[0034] The raw materials for preparing the second disintegrating body include: 50% to 60% anhydrous lactose, 20% to 30% starch, 2% to 10% talc, and 5% to 15% cross-linked polyvinyl pyrrolidone;

[0035] The width of the isolation zone is 1-10 mm; the length of the second disintegrated body is 7-20 mm.

[0036] The pathfinder capsule provided in the present application can flexibly control the disintegration time of the second disintegrating body and the first disintegrating body of the pathfinder capsule according to time requirements, thereby controlling the time of excretion from the body.

[0037] The schematic diagram of the structure of the pathfinder capsule in this application is as follows Figure 1 As shown in the figure, 1 is the first disintegrating body, 2 is the second disintegrating body, 3 is the capsule coating, and 4 is the isolation zone. Among them, the first disintegrating body is a semi-capsule shape, that is, a combination of a hemisphere and a cylinder, which is a solid structure, and the second disintegrating body and the first disintegrating body form a capsule shape, that is, the diameter of the second disintegrating body is the same as the diameter of the first disintegrating body, and the second disintegrating body is a solid structure. The pathfinder capsule also includes a capsule coating, which is arranged on the surface of the first disintegrating body and on the surfaces at both ends of the second disintegrating body, and the portion of the surface of the second disintegrating body that is not provided with the capsule coating is an isolation zone.

[0038] The first disintegrating body is arranged at the two ends of the pathfinder capsule, and the second disintegrating body is arranged in the middle of the pathfinder capsule. The capsule coating completely wraps the surface of the first disintegrating body and extends to cover the two ends of the second disintegrating body. Only the surface of the isolation belt is not covered with the capsule coating. This ensures that the first disintegrating body is intact and the contrast agent therein does not leak before the second disintegrating body disintegrates to expose the first disintegrating body.

[0039] The tartaric acid and sodium bicarbonate in the first disintegrating body are often used as effervescent agents. After contacting with water, they will undergo a chemical reaction to generate carbon dioxide, causing the first disintegrating body to disintegrate rapidly. The higher the content of the tartaric acid and the sodium bicarbonate, the faster the disintegration speed. The first disintegrating body contains a contrast agent, which is barium sulfate, which is convenient for external equipment to detect capsules; the presence of the tartaric acid and sodium bicarbonate causes the first disintegrating body to disintegrate rapidly, preferably within 1 hour. In the first disintegrating body, the content of anhydrous lactose is 50-60wt%, specifically, the content of anhydrous lactose is 51-59wt%, more specifically, the content of anhydrous lactose is 51wt%, 52wt%, 53wt%, 54wt%, 55wt%, 56wt%, 57wt%, 58wt%, 59wt% or 60wt%, or other values ​​within the range; the content of starch is 5-10wt%, specifically, the content of starch is 5wt%, 6wt%, 7wt%, 8wt%, 9wt% or 10wt%, or other values ​​within the range; the content of talc is 2-5wt%, specifically, the content of talc is 2wt%, 3wt%, 4wt% or 5wt%. %, or other values ​​within the range; the content of tartaric acid is 10~15wt%, specifically, the content of tartaric acid is 10wt%, 11wt%, 12wt%, 13wt%, 14wt% or 15wt%, or other values ​​within the range; the content of sodium bicarbonate is 10~15wt%, specifically, the content of sodium bicarbonate is 10wt%, 11wt%, 12wt%, 13wt%, 14wt% or 15wt%, or other values ​​within the range; the content of the contrast agent is 10~15wt%, specifically, the content of the contrast agent is 10wt%, 11wt%, 12wt%, 13wt%, 14wt% or 15wt%, or other values ​​within the range.

[0040] In the second disintegrating body, anhydrous lactose is used as the main filler, and starch is used as a binder and mixed with anhydrous lactose to increase the overall viscosity, which is especially obvious after absorbing water. The more starch content, the greater the viscosity of the capsule after absorbing water, and the slower the disintegration rate; talcum powder is used as a lubricant to make the capsule easier to form during the tableting process, and cross-linked polyvinyl pyrrolidone is used as a disintegrant for the capsule. It has strong swelling properties after absorbing water, and the swelling makes the capsule body easier to disintegrate. Therefore, the higher its content, the faster the capsule disintegrates. According to the chemical properties of the components of the second disintegrating body, different component ratios can be used to obtain pathfinder capsules with different disintegration times. The content of the anhydrous lactose is 50-60wt%, specifically, the content of the anhydrous lactose is 50wt%, 51wt%, 52wt%, 53wt%, 54wt%, 55wt%, 56wt%, 57wt%, 58wt%, 59wt% or 60wt%, or other values ​​within the range; the content of the starch is 20-30wt%, specifically, the content of the starch is 20wt%, 21wt%, 22wt%, 23wt%, 24wt%, 25wt%, 26wt%, 27wt%, 28wt%, 29wt% or 30wt%, or other values ​​within the range Other values ​​within the range; the content of talcum powder is 2-10wt%, specifically, the content of talcum powder is 2wt%, 3wt%, 4wt%, 5wt%, 6wt%, 7wt%, 8wt%, 9wt% or 10wt%, or other values ​​within the range; the content of cross-linked polyvinyl pyrrolidone is 5-15wt%, specifically, the content of cross-linked polyvinyl pyrrolidone is 5wt%, 6wt%, 7wt%, 8wt%, 9wt%, 10wt%, 11wt%, 12wt%, 13wt%, 14wt% or 15wt%, or other values ​​within the range. In the present application, the second disintegrating body is preferably partially disintegrated within 30h, and the first disintegrating body is not exposed.

[0041] The compression density of the first disintegrating body and the second disintegrating body also affects their disintegration speed. The greater the compression density, the tighter the first disintegrating body and the second disintegrating body, the smaller the air gap between the materials inside, and the slower the disintegration speed. Conversely, the faster the disintegration speed. In order to make the second disintegrating body disintegrate within 30 hours, the compression density of the second disintegrating body is 1-1.5g / cm 3 Specifically, the compression density of the second disintegrated body is 1.0 g / cm 3 , 1.1g / cm 3 , 1.2g / cm 3 , 1.3g / cm 3 , 1.4g / cm 3 or 1.5g / cm 3, or other values ​​within the range; in order to make the first disintegrating body disintegrate rapidly within 1 hour, the compact density of the first disintegrating body is 1.4~1.8g / cm 3 Specifically, the compression density of the first disintegrated body is 1.4 g / cm 3 , 1.5g / cm 3 , 1.6g / cm 3 , 1.7g / cm 3 or 1.8 g / cm 3 , or other values ​​within the range.

[0042] The raw materials for preparing the capsule coating include one or more of parylene, ethyl cellulose and zein, and the thickness of the capsule coating is 10-100 μm.

[0043] Since the capsule coating does not allow digestive fluid to pass through, the disintegration process of the pathfinder capsule is as follows: the outer surface of the second disintegrating body in the isolation zone that contacts the digestive fluid disintegrates first, and after the second disintegrating body disintegrates to the point where the first disintegrating body is exposed to the digestive fluid, the first disintegrating body begins to disintegrate, and after the first and second disintegrating bodies have completely disintegrated, the remaining coating is excreted from the body with the intestine. It can be seen that the width of the isolation zone directly affects the area of ​​contact between the second disintegrating body and the digestive fluid, that is, the area of ​​the second disintegrating body material that disintegrates first. The larger this contact area, the faster the second disintegrating body disintegrates, and vice versa.

[0044] However, the size change of the pathfinder capsule does not necessarily increase the width of the isolation zone. For example, if the size of the pathfinder capsule increases, the overall size of the capsule can be increased only by increasing the size of the first disintegrating bodies at both ends. Under the condition that the capsule disintegration time does not change, there is no need to increase the width of the isolation zone. Since the disintegration time of the first disintegrating body is very short and negligible relative to the disintegration time of the second disintegrating body, increasing the size of the first disintegrating body has little effect on the overall disintegration time of the capsule, and there is no need to balance the disintegration time of the pathfinder capsule by increasing the width of the isolation zone. In this application, the width of the isolation zone ranges from 1 to 10 mm; the length of the second disintegrating body ranges from 7 to 20 mm. According to the width of the isolation zone, the disintegration time of the second disintegrating body can be adjusted to change between <30 h, 30 to 70 h, and >70 h. Under certain conditions of the ratio of raw materials for the preparation of the first disintegrating body and the second disintegrating body, in order to achieve the disintegration of the second disintegrating body in 30 to 70 hours, the width of the isolation zone ranges from 3 to 6 mm; the length of the second disintegrating body ranges from 10 to 15 mm.

[0045] The specific process of the pathfinder capsule in the body of the present application is as follows: after the pathfinder capsule is swallowed into the body, the isolation zone portion can come into contact with the digestive fluid, and the contact portion reacts and begins to slowly disintegrate. The speed of disintegration is related to the size of the contact area. The larger the contact area, the faster the disintegration speed of the second disintegrating body. For example, the second disintegrating body is configured to partially disintegrate within 30 hours of contact with the digestive fluid, but can still effectively connect to the first disintegrating body to support the capsule and maintain the capsule shape; when the patient's gastrointestinal tract is unobstructed, the pathfinder capsule will be excreted from the body within 30 hours, at which time the capsule still has a capsule shape, the first disintegrating body is intact, and the second disintegrating body is partially disintegrated; when the patient has gastrointestinal obstruction or stenosis, the pathfinder capsule will get stuck in the gastrointestinal tract, and when the capsule is in contact with the digestive fluid for more than 30 hours, the second disintegrating body continues to disintegrate and break, exposing the first disintegrating body to the digestive fluid, and the first disintegrating body disintegrates to release the contrast agent; the first disintegrating body and the second disintegrating body can be completely disintegrated within 72 hours, and eventually the remaining capsule coating collapses and is flattened, reducing its volume and being excreted from the body.

[0046] The present application also provides a method for preparing a pathfinder capsule, comprising the following steps:

[0047] S1) mixing anhydrous lactose, starch, talcum powder, tartaric acid, sodium bicarbonate and a contrast agent according to a proportion to obtain a first mixture, placing the first mixture in a hemispherical and cylindrical semi-capsule-shaped mold for compression to obtain a first disintegrating body;

[0048] Mixing anhydrous lactose, starch, talc and cross-linked polyvinyl pyrrolidone in a certain proportion to obtain a second mixture, and placing the second mixture in a cylindrical mold for compression to obtain a second disintegrating body;

[0049] S2) connecting the first disintegrating body and the second disintegrating body to obtain an initial pathfinder capsule;

[0050] S3) preparing capsule coating on the initial pathfinder capsule except the isolation zone to obtain a pathfinder capsule.

[0051] In the process of preparing the pathfinder capsule, the present application first prepares the first disintegrating body and the second disintegrating body, and according to the shape of the first disintegrating body, the first mixture obtained by mixing anhydrous lactose, starch, talcum powder, tartaric acid, sodium bicarbonate and contrast agent is placed in a semi-capsule-shaped mold for pressing, so as to obtain the first disintegrating body, and the semi-capsule-shaped mold is a combination mold of a hemisphere and a cylinder. The pressing pressure is 1~5T, and the time is 1~5min; specifically, the pressing pressure is 1T, 2T, 3T, 4T or 5T, and can also be other values ​​within the range; the time is 1min, 2min, 3min, 4min or 5min, and can also be other values ​​within the range. At the same time, according to the shape of the second disintegrating body, anhydrous lactose, starch, talc and cross-linked polyvinyl pyrrolidone are mixed to obtain a second mixture, and the second mixture is placed in a cylindrical mold for pressing to obtain a second disintegrating body, the pressing pressure is 1~5T, and the time is 1~5min. Specifically, the pressing pressure is 1T, 2T, 3T, 4T or 5T, and it can also be other values ​​within the range; the time is 1min, 2min, 3min, 4min or 5min, and it can also be other values ​​within the range; the hemispherical and cylindrical molds in the preparation process of the first disintegrating body and the cylindrical mold in the preparation process of the second disintegrating body need to ensure that the first disintegrating body and the second disintegrating body can form a capsule shape.

[0052] The present application then connects the first disintegrating body and the second disintegrating body to obtain an initial pathfinder capsule; in this process, the connection is performed in a manner well known to those skilled in the art. For example, the connection between the first disintegrating body and the second disintegrating body can be achieved by bonding. Specifically, an adhesive layer is evenly applied to the edge of the capsule body, and the first disintegrating body and the second disintegrating body are connected to obtain an initial pathfinder capsule.

[0053] According to the present invention, finally, the initial pathfinder capsule is coated with a capsule except for the isolation zone to obtain a pathfinder capsule. The method for preparing the capsule coating can be a coating method, a spraying method, or directly performed in a film coating machine, and the present application has no particular restrictions on this; for example, the pathfinder capsule is loaded into a fixed fixture, shielded by an isolation zone, the fixture is rotated at a constant speed, the coating liquid is put into a spray gun, and the coating liquid is dispersed into micron-sized mist particles based on pressure through an air pump, and sprayed on the surface of the uniformly rotating capsule to form a capsule coating. In the present application, the coating liquid includes parylene, ethyl cellulose or corn protein, etc.

[0054] The present application also provides the use of a pathfinder capsule in determining intestinal obstruction conditions, wherein the pathfinder capsule is the pathfinder capsule described in the above-mentioned scheme.

[0055] Furthermore, the application is specifically:

[0056] Administer the pathfinder capsule and observe whether the pathfinder capsule is completely discharged within 30 hours;

[0057] If so, capsule endoscopy is appropriate;

[0058] If not, capsule endoscopy is not appropriate.

[0059] The pathfinder capsule provided in the present application has a 360° contact surface with the digestive fluid, which can effectively prevent blockage during capsule disintegration, resulting in the inability to disintegrate and retention in the body; the capsule has a simple structure and is easy to produce and process, which can improve production efficiency; the non-degradable part of the capsule is composed of two half-capsule films, which are smaller in size and easier to be excreted from the body, reducing the risk of non-degradable substances remaining in the body.

[0060] In order to further understand the present invention, the pathfinder capsule provided by the present invention, its preparation method and application are described in detail below in conjunction with embodiments. The protection scope of the present invention is not limited by the following embodiments.

[0061] Example 1

[0062] (1) Weigh 1 g of anhydrous lactose, starch, talc, tartaric acid, sodium bicarbonate, and barium sulfate in a mass ratio of 50:10:5:12:12:11, mix the mixture, and put it into a hemispherical and cylindrical combination mold of a tablet press. The height of the hemispherical and cylindrical combination is controlled by the mold to be 6 mm. Under a pressure of 1 T, maintain the pressure for 2 minutes, open the mold, take out the pressed hemispherical and cylindrical combination, and obtain a first disintegrated body.

[0063] (2) Weigh 3 g of anhydrous lactose, starch, talc, and cross-linked polyvinyl pyrrolidone in a mass ratio of 50:30:10:10 and put them into a cylindrical mold of a tablet press. The total height of the cylinder is controlled by the mold to be 15 mm. Under a pressure of 1 T, maintain the pressure for 2 min, open the mold, take out the pressed cylinder, and obtain a second disintegrated body.

[0064] (3) preparing a 6 wt % adhesive liquid, applying a layer evenly on the edge of the capsule body to form an adhesive layer, connecting the first disintegrating body with the second disintegrating body and drying them to obtain an initial pathfinder capsule;

[0065] (4) The assembled initial pathfinder capsule is loaded into the fixed fixture. The middle of the second disintegration body is the isolation zone, which is covered with film to form a 5mm gap. The fixture is rotated at a constant speed, and the coating liquid is put into the spray gun. The air pump is used to apply the coating liquid at 5kg / cm 2 The pressure is applied to disperse it into micron-sized mist particles, which are sprayed on the surface of the uniformly rotating capsule to form an ethyl cellulose film with a thickness of 0.1 mm to obtain a pathfinder capsule.

[0066] Example 2

[0067] The preparation method is the same as that of Example 1, except that the isolation zone is 1 mm.

[0068] Example 3

[0069] The preparation method is the same as that of Example 1, except that the isolation zone is 3 mm.

[0070] Example 4

[0071] The preparation method is the same as that of Example 1, except that the isolation zone is 6 mm.

[0072] Example 5

[0073] The preparation method is the same as that of Example 1, except that the isolation zone is 10 mm.

[0074] Example 6

[0075] The preparation method is the same as that of Example 1, except that the mold controls the total height of the cylinder to be 7 mm.

[0076] Example 7

[0077] The preparation method is the same as that in Example 1, except that the mold controls the total height of the cylinder to be 10 mm.

[0078] Example 8

[0079] The preparation method is the same as that in Example 1, except that the mold controls the total height of the cylinder to be 15 mm.

[0080] Example 9

[0081] The preparation method is the same as that in Example 1, except that the mold controls the total height of the cylinder to be 20 mm.

[0082] Example 10

[0083] The preparation method is the same as that of Example 1, except that the mold controls the combined height of the hemisphere and the cylinder to be 12 mm.

[0084] Embodiment 11

[0085] The preparation method is the same as that in Example 1, except that the mold controls the combined height of the hemisphere and the cylinder to be 2 mm.

[0086] Example 12

[0087] The preparation method is the same as that in Example 1, except that the total mass weighed in step (2) is 1 g.

[0088] Embodiment 13

[0089] The preparation method is the same as that in Example 1, except that the total mass weighed in step (2) is 5 g.

[0090] Embodiment 14

[0091] The preparation method is the same as that in Example 1, except that the mass ratio of the raw materials in step (2) is 50:5:10:35: anhydrous lactose, starch, talc, and cross-linked polyvinyl pyrrolidone.

[0092] Embodiment 15

[0093] The preparation method is the same as that of Example 1, except that the mass ratio of the raw materials in step (2) is 50:35:10:5: anhydrous lactose, starch, talc, and cross-linked polyvinyl pyrrolidone.

[0094] The disintegration time of the pathfinder capsule prepared in the above embodiment was tested, and the testing method was as follows:

[0095] Prepare artificial gastric juice: take 16.4 mL of dilute hydrochloric acid, add 800 mL of water and 10 g of pepsin and dilute to 1000 mL; dilute hydrochloric acid is 234 mL of concentrated hydrochloric acid diluted to 1000 mL with water to obtain 9.5%~10.5% dilute hydrochloric acid;

[0096] Prepare artificial intestinal fluid: take 6.8g of potassium dihydrogen phosphate, add 500ml of water to dissolve it, and adjust the pH to 6.8 with 0.4% sodium hydroxide solution; take 10g of pancreatic enzyme (meeting the requirements of the pharmacopoeia), add appropriate amount of water to dissolve it; mix the two liquids, and dilute with water to 1000ml to obtain artificial intestinal fluid;

[0097] 500 ml of artificial gastric juice and artificial intestinal juice were put into the beaker of the disintegration instrument. The up and down swing of the disintegration instrument was used to replace gastrointestinal peristalsis. After the pathfinder capsule was swung in the artificial gastric juice for 2 hours, it was taken out and put into the artificial intestinal juice. The swing was continued to observe the disintegration of the capsule and the disintegration time was recorded. The results are shown in Table 1.

[0098] Table 1 Disintegration time data of Tanlu capsule

[0099] According to the test results of Examples 1 to 5, the disintegration time of the timing portion can be controlled by controlling the width of the isolation zone, and the preferred range of the isolation zone width that can achieve a disintegration time of 30 to 72 hours is 3 to 6 mm;

[0100] According to the test results of Examples 1 and 6 to 9, the disintegration time of the timing portion can also be controlled by controlling the length of the timing portion, and the preferred range of the timing portion length that can achieve a disintegration time of 30 to 72 hours is 10 to 15 mm;

[0101] According to the test results of Examples 1 and 10-11, changing the length of the contrast release portion does not affect the overall disintegration time.

[0102] According to the test results of Examples 1 and 12-13, it can be seen that the disintegration time can be controlled by changing the density of the second disintegrating body.

[0103] According to the test results of Examples 1 and 14-15, it can be seen that the disintegration time can be controlled by changing the material ratio of the second disintegrating body.

[0104] Example 13 Animal experiment using experimental pigs

[0105] Before the experiment, the experimental animals were prepared for intestinal tract according to the method of capsule endoscopy: one end of the pathfinder capsule to be tested was fixed with a traction rope, and the fixed position was the non-isolation zone part of the outer surface of the pathfinder capsule coating, which was used to prevent the pathfinder capsule from being discharged from the experimental animal in advance; during the experiment, the pathfinder capsule was sent into the duodenum of the experimental animal by an electronic gastroscope, and the length of the traction rope was fixed so that the pathfinder capsule was always in the intestine of the experimental animal in a complete state. After the pathfinder capsule was sent into the experimental animal, the experimental animal was subjected to a CT scan at 30 hours and 72 hours after the capsule was sent in, respectively, to observe the disintegration of the pathfinder capsule in the experimental animal.

[0106] The results of the animal experiments are shown in Table 2;

[0107] Table 2 Animal experiment results data table

[0108] The above embodiments are only used to help understand the method and core idea of ​​the present invention. It should be noted that, for those skilled in the art, several improvements and modifications can be made to the present invention without departing from the principles of the present invention, and these improvements and modifications also fall within the scope of protection of the claims of the present invention.

[0109] The above description of the disclosed embodiments enables one skilled in the art to implement or use the present invention. Various modifications to these embodiments will be apparent to one skilled in the art, and the general principles defined herein may be implemented in other embodiments without departing from the spirit or scope of the present invention. Therefore, the present invention will not be limited to the embodiments shown herein, but rather to the widest scope consistent with the principles and novel features disclosed herein.

Claims

1. A pathfinder capsule, comprising a first disintegrating body, a second disintegrating body and a capsule coating; The first disintegrating body is a semi-capsule-shaped solid structure, which is arranged at both ends of the pathfinder capsule; the second disintegrating body is a cylindrical solid structure, which forms a capsule shape with the first disintegrating body; the capsule coating is arranged on the surface of the first disintegrating body and the surfaces at both ends of the second disintegrating body, and the portion of the surface of the second disintegrating body that is not provided with the capsule coating is an isolation zone; The raw materials for preparing the first disintegrating body include: 50-60wt% anhydrous lactose, 5-10wt% starch, 2-5wt% talc, 10-15wt% tartaric acid, 10-15wt% sodium bicarbonate, and 10-15wt% contrast agent; The raw materials for preparing the second disintegrating body include: 50% to 60% anhydrous lactose, 20% to 30% starch, 2% to 10% talc, and 5% to 15% cross-linked polyvinyl pyrrolidone; The width of the isolation zone is 1-10 mm; the length of the second disintegrated body is 7-20 mm.

2. The pathfinder capsule according to claim 1, characterized in that: The compression density of the second disintegrating body is 1-1.5 g / cm 3 The compression density of the first disintegrated body is 1.4-1.8 g / cm 3 .

3. The pathfinder capsule according to claim 1, characterized in that: The raw materials for preparing the capsule coating include one or more of parylene, ethyl cellulose and zein, and the thickness of the capsule coating is 10-100 μm.

4. The pathfinder capsule according to claim 1, characterized in that: The raw materials for preparing the first disintegrating body include: 52-58wt% anhydrous lactose, 6-8wt% starch, 3-4wt% talc, 12-14wt% tartaric acid, 12-14wt% sodium bicarbonate, and 11-14wt% contrast agent; The raw materials for preparing the second disintegrating body include: 52% to 58% anhydrous lactose, 22% to 27% starch, 3% to 8% talc, and 6% to 14% cross-linked polyvinyl pyrrolidone.

5. The pathfinder capsule according to claim 1, characterized in that: The width of the isolation zone is 3-6 mm; the length of the second disintegrated body is 10-15 mm.

6. The method for preparing the pathfinder capsule according to claim 1, comprising the following steps: S1) mixing anhydrous lactose, starch, talcum powder, tartaric acid, sodium bicarbonate and a contrast agent according to a proportion to obtain a first mixture, placing the first mixture in a hemispherical and cylindrical semi-capsule-shaped mold for compression to obtain a first disintegrating body; Mixing anhydrous lactose, starch, talc and cross-linked polyvinyl pyrrolidone in a certain proportion to obtain a second mixture, and placing the second mixture in a cylindrical mold for compression to obtain a second disintegrating body; S2) connecting the first disintegrating body and the second disintegrating body to obtain an initial pathfinder capsule; S3) preparing a capsule coating at a position of the initial pathfinder capsule except the isolation zone to obtain a pathfinder capsule.

7. The preparation method according to claim 6, characterized in that: In step S1), in the step of obtaining the first disintegrated body, the pressing pressure is 1-5T and the time is 1-5min; in the step of obtaining the second disintegrated body, the pressing pressure is 1-5T and the time is 1-5min.

8. The preparation method according to claim 6, characterized in that: Step S3) is specifically as follows: The isolation belt of the initial pathfinder capsule is covered, and then the coating liquid is sprayed on the surface of the initial capsule by using a spray gun; the coating liquid includes one of parylene, ethyl cellulose or corn protein, and the pressure of the spray gun is 1-10 kg / cm 2 .

9. Use of a pathfinder capsule in determining intestinal obstruction, the pathfinder capsule being the pathfinder capsule described in any one of claims 1 to 5 or the pathfinder capsule prepared by the preparation method described in any one of claims 6 to 8.

10. The use according to claim 9, characterized in that: The application is specifically: Administer the pathfinder capsule and observe whether the pathfinder capsule is completely discharged within 30 hours; If so, capsule endoscopy is appropriate; If not, capsule endoscopy is not appropriate.